Skip to content
AnalystLens
Back to MRNAIncome Statement

Moderna, Inc. G&A Expense 2016-2026 | MRNA

Annual FY2016–FY2025 · quarterly through Q1 FY2026

Latest annual · FY2025

$1.02B

−13.3%YoY vs FY2024Source: 10-KFY2025

From $57.5M in FY2016 to $1.02B in FY2025: 17.7× in 9 years.

By quarter▲▼ vs a year before
Fiscal yearQ1Q2Q3Q4
FY26$173M−18.4%Not reportedNot reportedNot reported
FY25$212M−22.6%$230M−14.2%$268M−4.6%$308M−12.3%
FY24$274M−10.2%$268M−19.3%$281M−36.4%$351M−25.3%
FY23$305M+13.8%$332M+57.3%$442M+59.0%$470M+25.3%
FY22$268M+248.1%$211M+74.4%$278M+65.5%$375M+86.6%
Share20%22%26%32%

Shaded by size: darkest is the largest quarter shown; ringed is the latest reported; a dash marks a quarter with no separate figure. Each quarter sits by its period-end date. Share: its typical part of the fiscal year.

Key Statistics

Trend DirectionDeclining
CAGR

+40.2%

FY2020
$188.0M
FY2025
$1.02B

5 years selected · on the chart

G&A Expense History

Year-over-year comparison from 10-K annual reports

  1. $1.02B
YoY changeLargest recent move+201.6%in FY21Latest −13.3%

1 older move runs past ±150% (largest +201.6%); point at, tap or drag across the bars to read one.

G&A Expense, period by period

PeriodValueChangeSource
FY2025$1.02B−13.3%10-K
FY2024$1.17B−24.2%10-K
FY2023$1.55B+36.8%10-K
FY2022$1.13B+99.6%10-K
FY2021$567.0M+201.6%10-K
FY2020$188.0M+70.9%10-K
FY2019$110.0M+16.7%10-K
FY2018$94.3M+45.6%10-K
FY2017$64.7M+12.7%10-K
FY2016$57.5M—10-K

What is g&a expense?

General and administrative expenses cover corporate overhead costs including management salaries, office expenses, and administrative costs.

What is Moderna, Inc.'s current g&a expense?

Moderna, Inc. (MRNA) annual g&a expense for 2025 was $1.02B, a 13.29% decline from 2024. Moderna, Inc. g&a expense for the quarter ending March 31, 2026 was $173.0M.

What was Moderna, Inc.'s g&a expense in 2024?

Moderna, Inc. annual g&a expense for 2024 was $1.17B, a 24.21% decline from 2023.

What was Moderna, Inc.'s g&a expense in 2023?

Moderna, Inc. annual g&a expense for 2023 was $1.55B, a 36.84% increase from 2022.

What is Moderna, Inc.'s 5-year g&a expense CAGR?

Moderna, Inc. g&a expense grew at a compound annual growth rate (CAGR) of 40.19% from FY2020 to FY2025, going from $188.0M to $1.02B over 5 years.

Company
Moderna, Inc.
Ticker
MRNA
Sector
Healthcare
Industry
Biological Products, (No Diagnostic Substances)